Mamoun Dib

4.2k total citations
14 papers, 696 citations indexed

About

Mamoun Dib is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mamoun Dib has authored 14 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Mamoun Dib's work include Multiple Myeloma Research and Treatments (9 papers), Cancer Treatment and Pharmacology (3 papers) and Protein Degradation and Inhibitors (2 papers). Mamoun Dib is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Cancer Treatment and Pharmacology (3 papers) and Protein Degradation and Inhibitors (2 papers). Mamoun Dib collaborates with scholars based in France, United States and Belgium. Mamoun Dib's co-authors include Philippe Moreau, Cyrille Hulin, Thierry Façon, Philippe Casassus, Brigitte Pegourié, Laurent Garderet, Chantal Doyen, Claire Mathiot, Olivier Decaux and Lotfi Benboubker and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mamoun Dib

14 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mamoun Dib France 9 644 459 341 75 41 14 696
Norbert Pescosta Italy 11 455 0.7× 420 0.9× 276 0.8× 62 0.8× 55 1.3× 23 614
Zdeněk Adam Czechia 11 521 0.8× 418 0.9× 313 0.9× 81 1.1× 19 0.5× 30 586
MQ Lacy United States 11 408 0.6× 347 0.8× 229 0.7× 81 1.1× 36 0.9× 11 517
Raid G. Ossi United States 3 499 0.8× 329 0.7× 268 0.8× 53 0.7× 37 0.9× 4 545
Roberto Mina Italy 15 564 0.9× 483 1.1× 380 1.1× 84 1.1× 37 0.9× 51 679
Jose Estevam United States 11 627 1.0× 566 1.2× 361 1.1× 82 1.1× 45 1.1× 16 754
PR Greipp United States 11 577 0.9× 414 0.9× 289 0.8× 114 1.5× 38 0.9× 12 635
Jeana Cromer United States 6 802 1.2× 557 1.2× 413 1.2× 64 0.9× 63 1.5× 6 870
Daniele Derudas Italy 9 494 0.8× 369 0.8× 258 0.8× 127 1.7× 51 1.2× 30 624
M. Fox United States 4 487 0.8× 380 0.8× 297 0.9× 63 0.8× 20 0.5× 9 563

Countries citing papers authored by Mamoun Dib

Since Specialization
Citations

This map shows the geographic impact of Mamoun Dib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoun Dib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoun Dib more than expected).

Fields of papers citing papers by Mamoun Dib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoun Dib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoun Dib. The network helps show where Mamoun Dib may publish in the future.

Co-authorship network of co-authors of Mamoun Dib

This figure shows the co-authorship network connecting the top 25 collaborators of Mamoun Dib. A scholar is included among the top collaborators of Mamoun Dib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoun Dib. Mamoun Dib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Touzeau, Cyrille, Philippe Moreau, Aurore Perrot, et al.. (2020). Daratumumab + bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA.. Journal of Clinical Oncology. 38(15_suppl). 8538–8538. 5 indexed citations
2.
Mahieu, Rafaël, Mamoun Dib, P. Abgueguen, et al.. (2018). On the Nose: Disseminated Mucormycosis. The American Journal of Medicine. 131(10). 1182–1184. 1 indexed citations
3.
Dib, Mamoun, et al.. (2017). Primary mucosa-associated lymphoid tissue lymphoma of the entire esophagus. Gastrointestinal Endoscopy. 86(3). 560–561. 6 indexed citations
4.
Jaccard, Arnaud, Anne Lazareth, Lionel Karlin, et al.. (2014). A Prospective Phase II Trial of Lenalidomide and Dexamethasone ( LEN-DEX) in POEMS Syndrome. Blood. 124(21). 36–36. 8 indexed citations
5.
Avet‐Loiseau, Hervé, Denis Caillot, Gérald Marit, et al.. (2010). Long-Term Maintenance with Lenalidomide Improves Progression Free Survival In Myeloma Patients with High-Risk Cytogenetics: An IFM Study. Blood. 116(21). 1944–1944. 13 indexed citations
6.
Hulin, Cyrille, Thierry Façon, Philippe Rodon, et al.. (2009). Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial. Journal of Clinical Oncology. 27(22). 3664–3670. 266 indexed citations
7.
Josselin, N., Hélène Libouban, Mamoun Dib, et al.. (2008). Quantification of Dendritic Cells and Osteoclasts in the Bone Marrow of Patients with Monoclonal Gammopathy. Pathology & Oncology Research. 15(1). 65–72. 11 indexed citations
8.
Schmidt, Aline, Odile Blanchet, Mamoun Dib, et al.. (2007). Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study. European Journal Of Haematology. 78(6). 500–509. 18 indexed citations
9.
10.
Leleu, Xavier, Thomas Gastinne, Alban Godon, et al.. (2007). Hyperdiploidy Is a Common Finding in Monoclonal Gammopathy of Undetermined Significance and Monosomy 13 Is Restricted to These Hyperdiploid Patients. Clinical Cancer Research. 13(20). 6026–6031. 26 indexed citations
11.
12.
13.
Raucourt, Emmanuelle de, et al.. (2003). High‐dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. American Journal of Hematology. 74(3). 187–190. 36 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norbert Pescosta Breakdown of academic impact, for papers by Zdeněk Adam Breakdown of academic impact, for papers by MQ Lacy Breakdown of academic impact, for papers by Raid G. Ossi Breakdown of academic impact, for papers by Roberto Mina Breakdown of academic impact, for papers by Jose Estevam Breakdown of academic impact, for papers by PR Greipp Breakdown of academic impact, for papers by Jeana Cromer Breakdown of academic impact, for papers by Daniele Derudas Breakdown of academic impact, for papers by M. Fox
Rankless by CCL
2026